Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,179.17
    +3,053.14 (+6.48%)
     

  • CMC Crypto 200

    1,363.79
    +86.81 (+6.80%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
MONEY:

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

Orion Oyj
·2-min read
Orion Oyj
Orion Oyj

ORION CORPORATION
MANAGERS’ TRANSACTIONS
22 APRIL 2024 at 9.45 EEST

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Veli-Matti Mattila
Position: Member of the Board/Deputy member
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 59158/6/8

ADVERTISEMENT

____________________________________________
Transaction date: 2024-04-19
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: GIFT,DONATION OR INHERITANCE (RECEIVED)

Transaction details
(1): Volume: 460 Unit price: 0 EUR

Aggregated transactions (1):
Volume: 460 Volume weighted average price: 0 EUR
____________________________________________
Transaction date: 2024-04-19
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: GIFT,DONATION OR INHERITANCE (RECEIVED)

Transaction details
(1): Volume: 386 Unit price: 0 EUR

Aggregated transactions (1):
Volume: 386 Volume weighted average price: 0 EUR

Orion Corporation

Liisa Hurme

President and CEO

   

Olli Huotari

SVP, Corporate Functions

 

                                                

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.